Gaithersburg, MD, United States of America

Stephen L Hoffman

This inventor holds 34 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in Vaccine Development. Top assignees: Sanaria Inc., USA as Represented by Secretary of the Navy, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1992-2025.

USPTO Granted Patents = 34 (Patent Applications = 5)

% Patents Active = 94.1

CIPO Patents = 1

EPO Patents = 6 (Patent Applications = 2)

Average Co-Inventor Count = 3.3

ph-index = 9

Forward Citations = 189(Granted Patents)

Location History:

Rockville, MD (US) (2010 - 2023)
Gaithersburg, MD (US) (1992 - 2024)

Company Filing History:

USA as Represented by Secretary of the Navy

patents

3 out of 3,688

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

4. 2 out of 3,790

Johns Hopkins University

patents

5. 2 out of 2

Protein Potential, LLC

patents

6. 2 out of 750

The Rockefeller University

patents

7. 1 out of 1

Antigen Discovery, Inc.

patent

8. 1 out of 545

Glaxosmithkline Biologicals Sa

patents

9. 1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1992-2025

Loading Chart...

Areas of Expertise:

Live Attenuated Vaccine

Plasmodium Sporozoites

Neutralizing Antibodies

Mosquito Salivary Gland

Vaccine Compositions

Malaria Protection

Dengue Vaccines

Protective Immunogens

Antibody Assays

Haematophagous Organisms

Cytokine Responses

Polynucleotide Vaccines

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12409213 - Live attenuated oral vaccine against shigellosis and typhoid fever (2025-09-09),

2. 12171822 - Infectious plasmodium sporozoites grown in vitro (2024-12-24),

3. 11883475 - Infectioussporozoites grown in vitro (2024-01-30),

4. 11760794 - Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use (2023-09-19),

5. 11503819 - Apparatus and method of use for an automated mosquito salivary gland extraction device (2022-11-22),

6. 11324814 - Live attenuated oral vaccine against ETEC and typhoid fever (2022-05-10),

7. 11207395 - Infectious plasmodium sporozoites grown in vitro (2021-12-28),

8. 11021535 - Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use (2021-06-01),

9. 10781419 - Mosquito salivary gland extraction device and methods of use (2020-09-22),

10. 10695415 - Live attenuated oral vaccine against shigellosis and typhoid fever (2020-06-30),

11. 10441646 - Infectious plasmodium sporozoites grown in vitro (2019-10-15),

12. 10272146 - Purified plasmodium and vaccine compositions (2019-04-30),

13. 10197577 - Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines (2019-02-05),

14. 9878026 - Infectious plasmodium sporozoites grown in vitro (2018-01-30),

15. 9642909 - [object Object] (2017-05-09),

Title: The Inventor Stephen L Hoffman: Pioneering Innovations in Gaithersburg

Introduction: Stephen L Hoffman is a distinguished inventor based in Gaithersburg, MD, known for his groundbreaking contributions to various fields.

Latest Patents: Stephen L Hoffman's latest patents include cutting-edge technologies in the healthcare sector, focusing on advancements in medical devices and treatments.

Career Highlights: With a career spanning over two decades, Stephen L Hoffman has established himself as a leading figure in the innovation landscape, with numerous patents to his name.

Collaborations: Throughout his career, Stephen L Hoffman has collaborated with top research institutions, universities, and companies to bring his inventions to life, showcasing his ability to work across diverse teams.

Conclusion: Stephen L Hoffman's relentless pursuit of innovation and collaboration has solidified his position as a visionary inventor, shaping the future of technology and healthcare.